Source evidence
Backers
V-Bio Ventures
Active Belgian life sciences VC investing in biotech and drug development companies.
Something wrong or missing? Send an update. Fixed within 24 hours.
D
AgomAb Therapeutics Series A
Contemporaneous report gives initial €21m Series A and participating investors; later company extension release corroborates €21m announced in April.